4/A//SEC Filing
MERZOUKI ABDERRAZZAK 4/A
Accession 0001128732-19-000030
CIK 0001402328other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 8:55 AM ET
Size
4.7 KB
Accession
0001128732-19-000030
Insider Transaction Report
Form 4/AAmended
MERZOUKI ABDERRAZZAK
DirectorChief Operating Officer
Transactions
- Award
Common Stock
2018-06-20$0.00/sh+27,000,000$27,000→ 79,000,000 total
Documents
Issuer
Sunshine Biopharma, Inc
CIK 0001402328
Entity typeother
Related Parties
1- filerCIK 0001636418
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 8:55 AM ET
- Size
- 4.7 KB